Reviewer's report 
 Complement activation capacity in plasma before and during high-dose prednisolone Title: 
treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis. 
 4  24 June 2005 Version: Date: 
 Ole Haagen H Nielsen Reviewer: 
Reviewer's report: 
General 
I'm satisfied with all corrections made in the revised manuscript in accordance with my 1st revies of 
April 10, 2005. It's an interesting paper now worth for publication. 
------------------------------------------------------------------------------- 
Major Compulsory Revisions (that the author must respond to before a decision on publication can 
be reached) 
------------------------------------------------------------------------------- 
Minor Essential Revisions (such as missing labels on figures, or the wrong use of a term, which the 
author can be trusted to correct) 
------------------------------------------------------------------------------- 
Discretionary Revisions (which the author can choose to ignore) 
 Accept without revision What next?: 
 An article of importance in its field Level of interest: 
 Acceptable Quality of written English: 
 No Statistical review: 
Declaration of competing interests: 
I declare that I have no competing interests. 
Reviewer's report 
 Complement activation capacity in plasma before and during high-dose prednisolone Title: 
treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis. 
 4  24 June 2005 Version: Date: 
 Ole Haagen H Nielsen Reviewer: 
Reviewer's report: 
General 
I'm satisfied with all corrections made in the revised manuscript in accordance with my 1st revies of 
April 10, 2005. It's an interesting paper now worth for publication. 
------------------------------------------------------------------------------- 
Major Compulsory Revisions (that the author must respond to before a decision on publication can 
be reached) 
------------------------------------------------------------------------------- 
Minor Essential Revisions (such as missing labels on figures, or the wrong use of a term, which the 
author can be trusted to correct) 
------------------------------------------------------------------------------- 
Discretionary Revisions (which the author can choose to ignore) 
 Accept without revision What next?: 
 An article of importance in its field Level of interest: 
 Acceptable Quality of written English: 
 No Statistical review: 
Declaration of competing interests: 
I declare that I have no competing interests. 
Please review this paper.
user
Reviewer's report 
 Complement activation capacity in plasma before and during high-dose prednisolone Title: 
treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis. 
 4  24 June 2005 Version: Date: 
 Ole Haagen H Nielsen Reviewer: 
Reviewer's report: 
General 
I'm satisfied with all corrections made in the revised manuscript in accordance with my 1st revies of 
April 10, 2005. It's an interesting paper now worth for publication. 
------------------------------------------------------------------------------- 
Major Compulsory Revisions (that the author must respond to before a decision on publication can 
be reached) 
------------------------------------------------------------------------------- 
Minor Essential Revisions (such as missing labels on figures, or the wrong use of a term, which the 
author can be trusted to correct) 
------------------------------------------------------------------------------- 
Discretionary Revisions (which the author can choose to ignore) 
 Accept without revision What next?: 
 An article of importance in its field Level of interest: 
 Acceptable Quality of written English: 
 No Statistical review: 
Declaration of competing interests: 
I declare that I have no competing interests. 
assistant